Biolife stock.

May 10, 2023 · BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ... Stock analysis for Biolife Sciences Inc (BLFE:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.BANNOCKBURN, Ill., March 27, 2023--BioLife Plasma Services, part of the global biopharmaceutical company Takeda, today announced the opening of its 200th plasma donation center in the United ...BioLife Sciences Inc. (“BioLife" or the "Company") (OTCPK: BLFE) specializes in moving innovative products from the lab or small-scale production. BLFE : 0.0001 (unch) BioLife Sciences Retains GS Whitney & Co for Corporate Relations Globe Newswire - Wed Aug 3, 2022. HENDERSON, NV, Aug. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife ...BioLife Solutions, Inc. (BLFS) Stock Price, Quote & News - Stock Analysis BioLife Solutions, Inc. ( BLFS) NASDAQ · USD 11.99 -0.06 (-0.50%) Oct 16, 2023, 10:35 …

Company profile page for BioLife Plasma Services LP including stock price, company news, press releases, executives, board members, and contact informationWeb

BioLife Solutions Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time BLFS stock price.BioLife Solutions (NASDAQ:BLFS) recently announced preliminary results for FY2017. The company expects full-year 2017 revenue in the range of $11 million, which would be a gain of 34% from 2016. The solid growth in its revenue was driven by strong results from its worldwide distributors and higher sales to customers in the regenerative …

BioLife Solutions, Inc. announced that it has entered into a Securities Purchase Agreement with returning investor, Casdin Partners Master Fund, L.P. managed by Casdin Capital, LLC that it has issued 927,165 shares of common stock of the Company, par value $0.001 per share at a purchase price of $11.19 per share for an aggregate gross proceeds ...No changes to the price of Biolife Sciences Inc stock on the last trading day (Thursday, 30th Nov 2023). During the last trading day the stock fluctuated 100.00% from a day low at $0.0001 to a day high of $0.0002. The price has risen in 4 of the last 10 days and is up by 14900% over the past 2 weeks.Nov 3, 2023 · Bothell-based cold storage company BioLife Solutions Inc. (Nasdaq: BLFS) has raised $10.4 million through a private placement to New York City-based investment firm Casdin Capital. BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ...

Overview News BioLife Solutions Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-2.37 Market Cap 557.24 M …

Biolife Solutions Cash Flow from Operations is currently at (4.59 M). Operating Cash Flow reveals the quality of Biolife Solutions' reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of …

BioLife Solutions, Inc. (NASDAQ:BLFS) Major Shareholder Casdin Partners Master Fund, L Acquires 58,465 Shares marketbeat.com - August 11 at 7:16 PM: Analysts Are Bullish on Top Healthcare Stocks: BioLife Solutions (BLFS), Synlogic (SYBX) markets.businessinsider.com - August 11 at 6:40 PMWebExhibit 99.3. Unaudited Pro Forma Condensed Combined Financial Information. GCI Merger. General Terms and Effects. On March 19, 2021, BioLife Solutions, Inc. (the “Company”),BioLife Solutions, Inc. announced that it has received $10.374976 million in funding from Casdin Capital, LLC. 10-19. CI. Lake Street Adjusts Price Target on BioLife Solutions to $25 From $34, Maintains Buy Rating. 08-09. MT. Transcript : BioLife Solutions, Inc., Q2 2023 Earnings Call, Aug 08, 2023. 08-09.WebBioLife Solutions Probability Of Bankruptcy is currently at 1.00%. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability …CBS founder, sole shareholder and CEO John Brothers received $11 million in cash and $4 million of BioLife common stock in consideration for the asset sale. Brothers, now Vice President, Advanced Freezer Technologies at BioLife, may earn up to an additional $15 million in cash or stock over the next five years, based on exceeding …Web

Beta 0.53. Rev. per Employee $608.79K. P/E Ratio 31.69. EPS $0.44. Yield 3.96%. Dividend $0.31. Ex-Dividend Date Mar 30, 2023. Short Interest 8.71M 10/31/23. % of Float Shorted 0.28%.Stock. Governance. Analyst Coverage. Company. Company. Company. Press Releases. Events. Leadership. Board of Directors. Scientific Advisory Board. Quality Management System. Patents. ... Prior to BioLife’s acquisition of SciSafe, Inc. in October 2020, Mr. Richardson was the President and Founder of SciSafe, Inc. from 2010 to 2020, …BioLife shares outstanding (as of March 19, 2021) 33,401,359 Merger consideration percentage 19.9 % Merger consideration shares 6,646,870 less: Merger consideration shares withheld to satisfy outstanding GCI stockholder obligations to GCI 10,400 Subtotal 6,636,470 BioLife stock price (as of May 3, 2021) $ 35.07 Value of issued shares $ …Get the latest Biolife Sciences Inc (BLFE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Nov 9, 2023 · BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.

Roderick de Greef appointed Chairman and Chief Executive Officer bringing 20+ years of prior BioLife experience. Garrie Richardson appointed Chief Revenue Officer. Preliminary Q3 revenue of $33.3 million and expect 2023 revenue at the low end of the previously announced guidance range . BOTHELL, Wash., Oct. 19, 2023 /PRNewswire/ - …Web

As part of the agreement announced Monday, BioLife will acquire the remaining 56 percent of privately held SAVSU Technologies in exchange for 1.1 million shares of BioLife stock (Nasdaq: BLFS ...Get the latest BioLife Solutions, Inc. (BLFS) stock quote, history, news and other vital information to help you with your stock trading and investing. See the company's performance outlook, earnings date, dividend and yield, fair value, ratings and more.On August 9, 2021, BioLife entered into an Agreement and Plan of Merger (the “Sexton Merger Agreement”) with BLFS Merger Sub, Inc., a Delaware corporation ... As consideration for the Sexton Merger (the “Sexton Merger Consideration”), holders of common stock, preferred stock and options of Sexton, other than the Company …BOTHELL - BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ('CGT') and broader biopharma markets, today announced the launch of Ultraguard, the first ever non-toxic, non-hazardous and non-flammable -70-degreeC phase change material ('PCM'), for ultra-low temperature (ULT) protection.Cold Chain Logistics Stocks: BioLife vs Cryoport. Regenerative Medicine. September 20. 2022. 9 mins read. A few months ago, we held a cage match between two of the leading gene-editing stocks. Basically, it ended in a draw, leaving us with a mini portfolio in this potentially lucrative but extremely volatile life sciences /nanotech market.... stock price multiplied by the number of shares outstanding. BioLife Solutions net worth as of December 01, 2023 is $0.58B. Compare BLFS With Other Stocks ...

BioLife Solutions Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time BLFS stock price.

View the latest BioLife Sciences Inc. (BLFE) stock price, news, historical charts, analyst ratings and financial information from WSJ.

CI. BioLife Sciences Inc. Announces the Launch of BioLife Copper-Infused Microfiber Towels. 2022. CI. BioLife Sciences Inc. announced that it expects to receive $20 million in funding. 2022. CI. BioLife Sciences Inc. Reports Earnings Results for the First Quarter Ended February 28, 2022. 2022.BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. 2831 Saint Rose Parkway Suite 200 Henderson, NV 89052 United StatesIn Stock . Qty: Qty: 1 $ $18.99 18. 99 () Includes selected options. Includes initial monthly payment and selected options. ... and herbs. Biolife provides the perfect amount of vitamins, minerals, antioxidants, and herbs. Biolife helps to bridge the nutrient gap in your diet. It offers immune support, increased energy, and mental alertness by ...BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38. Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Third Quarter 2023 Shareholder and Analyst ...biolife sciences inc. biolife sciences inc. 0.00 ‎-11.11% 0.0004Under the terms of the agreement, BioLife will pay $15 million in cash and $15 million in newly issued shares of BioLife common stock for 100% of the outstanding shares of SciSafe. SciSafe's shareholders are also eligible over the next four years to receive up to 626,000 additional shares of BioLife common stock based on the achievement of ...May 10, 2023 · BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ... BOTHELL, WA— January 12, 2015 — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues (“BioLife” or the “Company”), today announced preliminary revenue for the fourth quarter …BLFE | Complete BioLife Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

CryoStor®CS10 effectively mitigates temperature-induced molecular cell stress responses to maximize post-thaw viability and recovery for a variety of immune cell types, including T cells (data not shown) and B cells. Here, human B cells from 6 different donors cryopreserved in CryoStor®CS10 show reproducibly high viability after thawing, as ...WebBioLife Solutions was up solidly in Monday’s trading session on positive results from a Phase 3 study. ... Stock Market News. Economic News. Morning Brief. Personal Finance. Crypto News.Investors. Overview. Financial Highlights. Quarterly Results. Stock Information. Securities Report & Form 20-F. IR Events. We bring our values to life through actions based on Patient-Trust-Reputation-Business, in that order. We believe that if we focus first on Patients, Trust and Reputation, we know we will build a sustainable and high ...Instagram:https://instagram. canopy growth corporation stockmost affordable dental insurancecheap stock to buy right nowbriteco insurance reviews BIOLIFE : B Riley Raises BioLife Solutions' PT to $61 from $35.50 After Q4 Revenue Beats Street, Announces Stirling Ultracold Deal; Keeps Buy Rating 2021: MT BIOLIFE : Maxim Adjusts Price Target on BioLife Solutions to $60 From $40, Maintains Buy Rating 2021: MT how to buy nintendo sharesbest day to trade stocks Get the latest Biolife Sciences Inc (BLFE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Get BioLife Solutions Inc (BLFS.PH) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. wells fargo cameron park Biolife Solutions story: Exercise or conversion by Aby Mathew of 8854 shares of Biolife Solutions subject to Rule 16b 3 and other headlines for Biolife SolutionsTrack Biolife Solutions Inc (BLFS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors